powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1003343633
Payal Shooliz
MD
Endocrinology
Orange Park,
FL
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$257
Payment records
6
By payment type
Food and Beverage
$257
Top paying entities
Food and Beverage
$257
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (1)
CCN 100001
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
283
Beneficiaries
—
Total drug cost
$158K
Distinct drugs
11
Brand share
70.3%
Top prescribed drugs
Semaglutide
47 claims
Levothyroxine Sodium
44 claims
Tirzepatide
31 claims
Metformin Hcl
28 claims
Atorvastatin Calcium
25 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
69
Unique beneficiaries
—
Total services
100
Distinct HCPCS
3
Medicare payment
$8K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 415 Endocrinology providers in FL — bottom quintile (cohort median 962).